Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

被引:0
作者
P Fox
M Hudson
C Brown
S Lord
V Gebski
P De Souza
C K Lee
机构
[1] Central West Cancer Service,
[2] National Health and Medical Research Council (NHMRC) Clinical Trials Centre,undefined
[3] The University of Sydney,undefined
[4] University of Western Sydney,undefined
[5] School of Medicine,undefined
来源
British Journal of Cancer | 2013年 / 109卷
关键词
inflammation; renal cell cancer; survival; prognosis; biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:147 / 153
页数:6
相关论文
共 291 条
  • [1] Alexandrakis MG(2003)Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis Am J Clin Oncol 26 135-140
  • [2] Passam FH(2010)The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment Med Oncol 27 1060-1065
  • [3] Moschandrea IA(2011)Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer Clin Transl Oncol 13 499-503
  • [4] Christophoridou AV(2001)Inflammation and cancer: back to Virchow? Lancet 357 539-545
  • [5] Pappa CA(2008)Automated blood cell counts Am J Clin Pathol 130 104-116
  • [6] Coulocheri SA(2004)Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer Br J Cancer 90 1707-1709
  • [7] Kyriakou DS(2011)Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer Br J Cancer 104 1288-1295
  • [8] Aliustaoglu M(2009)Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 1073-1081
  • [9] Bilici A(2008)Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer J Gastroenterol Hepatol 23 e325-e329
  • [10] Ustaalioglu B(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134